TY - JOUR
T1 - Progressive renal fibrosis in routine polycystic kidney disease
T2 - An immunohistochemical observation
AU - Okada, Hirokazu
AU - Ban, Shinichi
AU - Nagao, Shizuko
AU - Takahashi, Hisahide
AU - Suzuki, Hiromichi
AU - Neilson, Eric G.
N1 - Funding Information:
E.G.N. was supported in part by grants DK-46282 and DK-55926 from the National Institutes of Health. The authors thank C. Hirata and S. Yamada for their technical assistance. Parts of this study were presented at the 30th and the 31st Annual Meeting of the American Society of Nephrology, San Antonio, TX, USA, November 2–5, 1997, and Philadelphia, PA, USA, October 25–28, 1998, respectively, and were published in abstract form (J Am Soc Nephrol 8:523, 1997; J Am Soc Nephrol 9:524, 1998).
PY - 2000
Y1 - 2000
N2 - Background. The appearance of interstitial fibrosis in polycystic kidneys is emblematic of progressive disease. Matrix forming this scar tissue is derived from local renal cells in response to cystogenesis. We investigated the phenotype of collagen producing cells in the cystic kidneys of DBA/2-pcy mice to better characterize the spectrum of interstitial cells associated with renal fibrogenesis. Methods. The extent of interstitial fibrosis and the number of fibroblasts in cystic kidneys were first quantitated over time using computer-assisted image analysis. Subsequently, antisera to four cell protein markers were studied by coexpression immunohistochemistry during progression of fibrosis using confocal microscopy. The antisera included fibroblast-specific protein 1 (FSP1) for fibroblast phenotype, α-smooth muscle actin (α-SMA) for contractile phenotype, vimentin (VIM) for mesenchymal phenotype, and heat shock protein 47 (HSP47) for interstitial collagen-producing phenotype. Results. Interstitial fibrosis in cystic kidneys gradually increased throughout the 30-week observation period of our study. With progression of cystogenesis, most of the tubules in pcy mice either dilate4d or disappeared with time. FSP1+ fibroblasts were distributed sparsely throughout the renal interstitium of young pcy and wild-type mice. Their number increased in the widening fibrotic septa by 18 weeks of age and persisted through 30 weeks of the study interval. Some epithelia among remnant tubules trapped within fibrotic septa around adjacent cysts also acquired the phenotype of FSP1+, HSP47+ collagen-producing fibroblasts, suggesting a possible role for epithelial-mesenchy-real transformation (EMT) in this process. Most FSP1+ fibroblasts were α-SMA-, but HSP47+, suggesting they were producing collagen proteins for the extracellular matrix, α-SMA+, FSP1-, HSP47+ or HSP47- cells were also observed, and the latter tended to distribute independently in a linear pattern, reminiscent of vasculature adjacent to forming cysts. VIM+ expression was not observed in α-SMA+ cells. Conclusions. Many nonoverlapping as well as fewer overlapping populations of FSP1+ and α-SMA+ cells shared in the collagen expression associated with progressive fibrogenesis in pcy mice undergoing cystogenesis. Some FSP1+ fibroblasts are likely derived from tubular epithelium undergoing EMT, while αSMA+, VIM- cells probably represent vascular smooth muscle cells or pericytes surviving vessel attenuation during the chaos of fibrogenesis. Importantly, not all interstitial cells producing collagens are α-SMA+.
AB - Background. The appearance of interstitial fibrosis in polycystic kidneys is emblematic of progressive disease. Matrix forming this scar tissue is derived from local renal cells in response to cystogenesis. We investigated the phenotype of collagen producing cells in the cystic kidneys of DBA/2-pcy mice to better characterize the spectrum of interstitial cells associated with renal fibrogenesis. Methods. The extent of interstitial fibrosis and the number of fibroblasts in cystic kidneys were first quantitated over time using computer-assisted image analysis. Subsequently, antisera to four cell protein markers were studied by coexpression immunohistochemistry during progression of fibrosis using confocal microscopy. The antisera included fibroblast-specific protein 1 (FSP1) for fibroblast phenotype, α-smooth muscle actin (α-SMA) for contractile phenotype, vimentin (VIM) for mesenchymal phenotype, and heat shock protein 47 (HSP47) for interstitial collagen-producing phenotype. Results. Interstitial fibrosis in cystic kidneys gradually increased throughout the 30-week observation period of our study. With progression of cystogenesis, most of the tubules in pcy mice either dilate4d or disappeared with time. FSP1+ fibroblasts were distributed sparsely throughout the renal interstitium of young pcy and wild-type mice. Their number increased in the widening fibrotic septa by 18 weeks of age and persisted through 30 weeks of the study interval. Some epithelia among remnant tubules trapped within fibrotic septa around adjacent cysts also acquired the phenotype of FSP1+, HSP47+ collagen-producing fibroblasts, suggesting a possible role for epithelial-mesenchy-real transformation (EMT) in this process. Most FSP1+ fibroblasts were α-SMA-, but HSP47+, suggesting they were producing collagen proteins for the extracellular matrix, α-SMA+, FSP1-, HSP47+ or HSP47- cells were also observed, and the latter tended to distribute independently in a linear pattern, reminiscent of vasculature adjacent to forming cysts. VIM+ expression was not observed in α-SMA+ cells. Conclusions. Many nonoverlapping as well as fewer overlapping populations of FSP1+ and α-SMA+ cells shared in the collagen expression associated with progressive fibrogenesis in pcy mice undergoing cystogenesis. Some FSP1+ fibroblasts are likely derived from tubular epithelium undergoing EMT, while αSMA+, VIM- cells probably represent vascular smooth muscle cells or pericytes surviving vessel attenuation during the chaos of fibrogenesis. Importantly, not all interstitial cells producing collagens are α-SMA+.
UR - http://www.scopus.com/inward/record.url?scp=0033865917&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033865917&partnerID=8YFLogxK
U2 - 10.1046/j.1523-1755.2000.00205.x
DO - 10.1046/j.1523-1755.2000.00205.x
M3 - Article
C2 - 10916082
AN - SCOPUS:0033865917
SN - 0085-2538
VL - 58
SP - 587
EP - 597
JO - Kidney International
JF - Kidney International
IS - 2
M1 - 4491725
ER -